BioSpace News Archive

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum on Thursday, November 19, 2020 . Even

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD). The device provides gentle vibration throu

Today, the U.S. Food and Drug Administration (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted 1 yes, 8 no and 2 uncertain on the question, “Does Study 302 (EMERGE), viewed independently and without regard for Study 301 (ENGAGE), provide strong evidence that supports the effectiveness of aducanumab for the treatment of Alzheimer’s disease?”. The Advisory Committee also voted 0 yes, 7 no and 4 uncertain on th

Graft delivery refers to the procedure in which a piece of living tissue is surgically transplanted.

The global hemophilia gene therapy market is predicted to increase at a stellar pace in the years to follow.

The evolution trajectories in the hepatitis B vaccine market is influenced and shaped by the various country-wide trends in hepatitis B vaccination in the worldwide population.

Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual meeting.

Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing.

EnACT study of MAT2203 in cryptococcal meningitis received unanimous D ata and Safety Monitoring Board (DSMB) recommendation to pro ceed into second patient cohort – ENHANCE-IT s tudy of MAT9001 against Vascepa ® fully enrolled with topline data anticipated Q1 2021 ; Phase 3 program on track to initiate H1 2021 – – Management to ho st conference call today, Friday , November 6 th , at 8 : 3 0 a .m. ET –

CareDx, Inc. announced it is “Lacing Up” with the National Kidney Foundation by joining the 2020 Pacific Northwest Virtual Kidney Walk to support kidney health and improve the lives of the 37 million people in the United States affected by kidney disease.